Tag: venture capital
-
Vaccine Developer Gains $11M in Early Funds
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round.
-
Infographic – Biotech Index Zooms to New High
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Touch Sensor Developer Gains $12M in Early Funds
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round.
-
Duke Univ Forms Drug Development Company
Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages.
-
Radiology A.I. Company Raises $4M in Seed Funds
A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round.
-
Medical Knowledge A.I. Company Raises Early $4.8M
A company developing a system with artificial intelligence to analyze medical literature for treatment insights is raising nearly $5 million in its first venture round.
-
Infographic – Q3 A.I. Health Investments Set Record
Venture capital funding for companies worldwide building artificial intelligence solutions in health care set new highs in the third quarter of 2019.
-
Engineered Organ Transplant Company Raises New Funds
An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing.
-
Fund Finances Start-Ups Outside Main Tech Hubs
A venture capital company unveiled a second seed-stage fund that finances start-up enterprises in the U.S. outside of Boston, New York, and Silicon Valley.